Видео ютуба по тегу Myqorzo

Myqorzo, The New FDA Approved Drug Targeting the Root Cause of Obstructive Hypertrophic Cardiomyopat
Myqorzo, The New FDA Approved Drug Targeting the Root Cause of Obstructive Hypertrophic Cardiomyopat
MYQORZO (афикамтен) - Кардиомиопатия
MYQORZO (афикамтен) - Кардиомиопатия
Cytokinetics Investor Conference Call on FDA Approval of MYQORZO™ | Dec 19, 2025
Cytokinetics Investor Conference Call on FDA Approval of MYQORZO™ | Dec 19, 2025
MYQORZO - FDA NDA approval - 2025-12-19
MYQORZO - FDA NDA approval - 2025-12-19
Cytokinetics (CYTK Stock) FDA Approves MyQorzo (aficamten) Obstructive Hypertrophic Cardiomyopathy
Cytokinetics (CYTK Stock) FDA Approves MyQorzo (aficamten) Obstructive Hypertrophic Cardiomyopathy
Афикамтен при обструктивной гипертрофической кардиомиопатии | NEJM
Афикамтен при обструктивной гипертрофической кардиомиопатии | NEJM
FDA Approval: Myqorzo for Adult Symptomatic Obstructive Hypertrophic Cardiomyopathy Treatment
FDA Approval: Myqorzo for Adult Symptomatic Obstructive Hypertrophic Cardiomyopathy Treatment
Myqorzo — лечение взрослых пациентов с симптоматической обструктивной гипертрофической кардиомиоп...
Myqorzo — лечение взрослых пациентов с симптоматической обструктивной гипертрофической кардиомиоп...
Why Myqorzo (aficamten) FDA Approval Is a Game Changer ? | Cardiomyopathy
Why Myqorzo (aficamten) FDA Approval Is a Game Changer ? | Cardiomyopathy
Cytokinetics MYQORZO FDA Approval: A Heart Disease Breakthrough!
Cytokinetics MYQORZO FDA Approval: A Heart Disease Breakthrough!
Fda Approves Myqorzo For Symptomatic Obstructive Hypertrophic Cardiomyopathy Mednews
Fda Approves Myqorzo For Symptomatic Obstructive Hypertrophic Cardiomyopathy Mednews
Important Safety Information
Important Safety Information
How Aficamten Works in Obstructive Hypertrophic Cardiomyopathy (HCM)
How Aficamten Works in Obstructive Hypertrophic Cardiomyopathy (HCM)
Mizuho's Jared Holz on what biotech dealmaking looks like in 2026
Mizuho's Jared Holz on what biotech dealmaking looks like in 2026
📢Notícia de última hora!#Aficamten (MYQORZO®) aprovados para comercialização na China! #dengyuemed
📢Notícia de última hora!#Aficamten (MYQORZO®) aprovados para comercialização na China! #dengyuemed
Cardiovasculary Update – January 15, 2026: TMVR approved, Aficamten cleared, Robotic EP and more
Cardiovasculary Update – January 15, 2026: TMVR approved, Aficamten cleared, Robotic EP and more